Effects of Feixian Formula on Expressions of wnt3a, β-catenin, WIF1 and LRP in Bleomycin-induced Pulmonary Interstitial Fibrosis in Rats Click Copy

Effects of Feixian Formula on Expressions of wnt3a, β-catenin, WIF1 and LRP in Bleomycin-induced Pulmonary Interstitial Fibrosis in Rats

References:

[1] 中华医学会呼吸病学分会间质性肺疾病学组.特发性肺纤维化诊断和治疗中国专家共识[J].中华结核和呼吸杂志,2016,39(6):427-432.

[2] LUPPI F, SPAGNOLO P, CERRI S, et al. The big clinical trials in idiopathic pulmonary fibrosis[J]. Curr Opin Pulm Med,2012, 18(5):428-432.

[3] RAGHU G, ROCHWERG B, ZHANG Y, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: Treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline[J]. American Journal of Respiratory & Critical Care Medicine,2015, 192(2):e3-19.

[4] QU B, LIU B R, DU Y J, et al. Wnt/β-catenin signaling pathway may regulate the expression of angiogenic growth factors in hepatocellular carcinoma[J]. Oncol Lett,2014,7(4):1175-1178.

[5] AANSTAS J N, MOON R T. WNT signalling pathways as therapeutic targets in cancer[J]. Nat Rev Cancer,2012,13(1):11-26.

[6] YANG Y, CHEN X X, LI W X, et al. EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis[J]. J Cell Mol Med,2017,21(10):2317-2328.

[7] 陈华,龚艺,周宝尚,等.MiR-200a抑制 Wnt/β-catenin信号通路缓解肾间质纤维化[J].中国临床药理学与治疗学,2017,22(4):381-386.

[8] 李娇,赵信科,魏惠平,等.Wnt信号通路与心肌纤维化的研究进展和应用前景[J].中国临床药理学杂志,2017,33(18):1828-1831.

[9] 张晓梅,姜良铎,张伟,等.肺纤方抗大鼠肺纤维化的实验研究[J].中华中医药杂志,2007,22(6):407-409.

[10] 王紫娟,张宇婷,顾潇枫,等.肺纤方加减治疗36例特发性肺纤维化患者CT积分改变及生活质量影响[J].中华中医药杂志,2018,33(8):3682- 3685.

[11] 于小林,张晓梅,张艳霞,等.肺纤维化动物模型研究近况[J].河南中医,2017,37(11):1926-1928.

[12] LIU T, DE LOS SANTOS F G, PHAN S H. The Bleomycin model of pulmonary fibrosis[J]. Methods Mol Biol,2017,1627:27-42.

[13] KIM T H, KIM S H, SEO J Y, et al. Blockade of the Wnt/β-catenin pathway attenuates bleomycin-induced pulmonary fibrosis[J]. Tohoku Journal of Experimental Medicine,2011,223(1):45.

[14] 刘茗心,陈菊屏.Wnt信号通路与肺纤维化的研究进展[J].现代医药卫生,2016,32(1):83-85.

Memo

基金项目:国家自然科学基金(81273696);北京中医药大学自主课题(2019-JYB-XS-205)